These advancements have the potential to significantly change how we treat metabolic diseases in the future
For commercially insured patients with coverage for Wegovy, the savings card may reduce your monthly cost to $0, with a maximum savings limit of $225/month
This uncertainty is clinically relevant, as understanding whether the CV benefit of semaglutide is independent of the modest weight loss that may occur during treatment could help clarify the extent to which these effects are mediated through mechanisms beyond weight reduction
There have been plenty of studies on older, less powerful drugs in the GLP-1 class, such as liraglutide, but semaglutide and tirzepatide represent new territory
This prescription is used to improve glycemic control and help in weight loss
This test, available for $99 as an add-on after your first month of treatment, maps 49 specific peptides and provides 150+ insights into why certain doses or medication combinations work better for you